Details

Autor(en) / Beteiligte

• Alcalai, Ronny
• Arad, Michael
• Wakimoto, Hiroko
• Yadin, Dor
• Gorham, Joshua
• Wang, Libin
• Burns, Elia
• Maron, Barry J
• Roberts, William C
• Konno, Tetsuo
• Conner, David A
• Perez-Atayde, Antonio R
• Seidman, Jon G
• Seidman, Christine E

Titel

LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart

Ist Teil von

• Journal of the American Heart Association, 2021-09, Vol.10 (17), p.e018829-e018829

Ort / Verlag

England: John Wiley and Sons Inc

Erscheinungsjahr

2021

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• Background Human mutations in the X-linked lysosome-associated membrane protein-2 ( ) gene can cause a multisystem Danon disease or a primary cardiomyopathy characterized by massive hypertrophy, conduction system abnormalities, and malignant ventricular arrhythmias. We introduced an mutation (denoted L2 ) causing human cardiomyopathy, into mouse gene, to elucidate its consequences on cardiomyocyte biology. This mutation results in deletion of 41 amino acids, compatible with presence of some defective LAMP2 protein. Methods and Results Left ventricular tissues from L2 and wild-type mice had equivalent amounts of RNA, but a significantly lower level of LAMP2 protein. By 20 weeks of age male mutant mice developed left ventricular hypertrophy which was followed by left ventricular dilatation and reduced systolic function. Cardiac electrophysiology and isolated cardiomyocyte studies demonstrated ventricular arrhythmia, conduction disturbances, abnormal calcium transients and increased sensitivity to catecholamines. Myocardial fibrosis was strikingly increased in 40-week-old L2 mice, recapitulating findings of human LAMP2 cardiomyopathy. Immunofluorescence and transmission electron microscopy identified mislocalization of lysosomes and accumulation of autophagosomes between sarcomeres, causing profound morphological changes disrupting the cellular ultrastructure. Transcription profile and protein expression analyses of L2 hearts showed significantly increased expression of genes encoding activators and protein components of autophagy, hypertrophy, and apoptosis. Conclusions We suggest that impaired autophagy results in cardiac hypertrophy and profound transcriptional reactions that impacted metabolism, calcium homeostasis, and cell survival. These responses define the molecular pathways that underlie the pathology and aberrant electrophysiology in cardiomyopathy of Danon disease.